Clicky

Emergent Biosolutions, Inc.(EBS) News

Date Title
Oct 15 Zacks.com featured highlights include Grupo Supervielle, Emergent BioSolutions and Innodata
Oct 14 3 Stocks Poised for Better Returns With New Analyst Coverage
Oct 11 Emergent BioSolutions Inc. (EBS): A Standout Among Best Performing Cheap Stocks in 2024
Oct 9 Emergent BioSolutions Inc (EBS) Q2 2024 Earnings Call Highlights: Navigating Challenges and ...
Oct 9 Emergent to donate 20,000 Narcan doses to fight opioid overdoses, CEO says
Sep 26 Emergent BioSolutions Announces the Execution of Contract Options Valued at $67.4 Million to Procure Additional TEMBEXA® (brincidofovir) to Support National Preparedness Efforts
Sep 25 Emergent BioSolutions Confirms Approximately $400 million in Orders in 2024 & 2025 to Support Smallpox and Mpox Preparedness Efforts
Sep 24 Emergent BioSolutions Inc.'s (NYSE:EBS) institutional investors lost 16% last week but have benefitted from longer-term gains
Sep 4 Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa to its Board of Directors
Sep 3 Emergent BioSolutions Successfully Refinances Debt & Further Strengthens Financial Profile
Aug 30 EBS Stock Rises on FDA Nod for ACAM2000 in Mpox Indication
Aug 30 Emergent BioSolutions Stock Soars as FDA Approves Mpox Vaccine
Aug 30 This Biotech Stock Surges As WHO Health Emergency Stirs FDA Approval
Aug 30 Emergent BioSolutions Expands Ready to Rescue Initiative to Support Widespread Opioid Emergency Preparedness
Aug 30 Emergent gains FDA approval for ACAM2000 vaccine for Mpox
Aug 29 Emergent BioSolutions’ ACAM2000®, (Smallpox and Mpox (Vaccinia) Vaccine, Live) Receives U.S. FDA Approval for Mpox Indication; Public Health Mpox Outbreak Continues Across Africa & Other Regions
Aug 26 Emergent to cut up to 70 roles at Lansing facility
Aug 7 Emergent BioSolutions (EBS) Q2 2024 Earnings Call Transcript
Aug 6 Emergent Biosolutions: Q2 Earnings Snapshot
Aug 6 Emergent BioSolutions Reports Second Quarter 2024 Financial Results